Kosnopfel C, Sinnberg T, Sauer B, et al. MAPK inhibitor resistant melanoma cells can be effectively targeted by inhibition of the p90 ribosomal S6 kinase. SMR 2017, abstract P01-9.
HRQOL en cognitieve functie na lomustine-temozolomide versus temozolomide
dec 2019 | Neuro-oncologie